Elucida Oncology’s Lead Clinical Candidate ELU001 to Be Featured in Two Abstracts at the American Association for Cancer Research Annual Meeting
MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
Legend Power Systems Schedules Q3 2026 Financial Results Release and Webinar for August 28, 2026
Shadow AI Is the New Shadow IT
Addressing Cross-Border Transit Demand at the New Huanggang Port: Weixin Pay, Wonder and Koon Wing Motors Join Forces to Introduce ‘Wonder Transit X’ Smart Mobility Platform, Driving Digital Transformation of Green Minibuses and Fostering Public Transit Integration Between HK and the Chinese Mainland
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
Onchain Foundation Becomes Strategic Shareholder of Trust Square Ecosystem AG to Accelerate Global Innovation Platform